[Adrenomedullin in pulmonary hypertension].
Nagaya
Noritoshi
N
Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute.
Kangawa
Kenji
K
D000280:Administration, Inhalation; D053607:Adrenomedullin; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D015415:Biomarkers / Q000097:blood; D002455:Cell Division / Q000187:drug effects; D003864:Depression, Chemical; D042783:Endothelial Cells / Q000166:cytology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D008168:Lung / Q000098:blood supply; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D010455:Peptides / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000502:physiology*; D014655:Vascular Resistance / Q000187:drug effects; D014664:Vasodilation
D015415:Biomarkers; D010455:Peptides; D053607:Adrenomedullin